SYNOVA-R-Final-Flat-400

RAISING $3MM TO $5MM

Regenerate yourself.  Synova Life Sciences is making it possible for patients to get treated with their own stem cells from their own fat at their own doctor’s office for osteoarthritis and musculoskeletal procedures through minimally-invasive, same-day, office procedures.

Categories: ,

Product Description

Synova Life Sciences

John Chi, MBt, CEO
info@synovalife.com
619-796-6821

www.synovalife.com

Biotechnology / Life Sciences

Synova is bringing technologies to market that will result in new standards of care for medicine and will fuel the growth of personalized regenerative medicine. We are currently developing of a device that extracts a patient’s own stem cells (autologous) from their own fat (adipose tissue) based on our patent-pending process. We are initially targeting osteoarthritis and musculoskeletal procedures so patients can be treated by their own doctors, through minimally-invasive, same-day, office procedures.

Transaction Type: Early Stage
Capital Requirements:  $3MM to $5MM
Offering Type: Debt/Equity
Investor Deck
Executive Summary
Business Plan and Proformas

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.